Skip to main content
PMC home page
Heart logoLink to Heart
. 2001 Dec;86(6):715–721. doi: 10.1136/heart.86.6.715

Surgery of valve disease: late results and late complications

P Groves 1
PMCID: PMC1730041  PMID: 11711480

Full Text

The Full Text of this article is available as a PDF (137.2 KB).

Figure 1:  .

Figure 1:  

Open in a new tab

Transoesophageal echocardiographic image showing multiple mobile thrombi (arrows) on the left atrial (LA) aspect of a prosthetic mitral valve (MV) in a patient who presented with transient cerebral ischaemia.

Figure 2:  .

Figure 2:  

Open in a new tab

Transoesophageal echocardiographic image showing systolic (right panel) and diastolic (left panel) frames of a peri-aortic cavity (arrow) in a patient with infective endocarditis on a prosthetic aortic valve. The systolic expansion of the cavity is caused by its communication with the left ventricular outflow tract.

Figure 3:  .

Figure 3:  

Open in a new tab

Transoesophageal echocardiographic image of an aortic prosthetic valve partly obstructed by pannus. Grey scale (left) and colour flow (right) images show that the movement of the occluder is limited in systole (arrow). LA, left atrium; LVOT, left ventricular outflow tract.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burke A. P., Farb A., Sessums L., Virmani R. Causes of sudden cardiac death in patients with replacement valves: an autopsy study. J Heart Valve Dis. 1994 Jan;3(1):10–16. [PubMed] [Google Scholar]
  2. Calderwood S. B., Swinski L. A., Waternaux C. M., Karchmer A. W., Buckley M. J. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985 Jul;72(1):31–37. doi: 10.1161/01.cir.72.1.31. [DOI] [PubMed] [Google Scholar]
  3. Cannegieter S. C., Rosendaal F. R., Wintzen A. R., van der Meer F. J., Vandenbroucke J. P., Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995 Jul 6;333(1):11–17. doi: 10.1056/NEJM199507063330103. [DOI] [PubMed] [Google Scholar]
  4. Cohen G., David T. E., Ivanov J., Armstrong S., Feindel C. M. The impact of age, coronary artery disease, and cardiac comorbidity on late survival after bioprosthetic aortic valve replacement. J Thorac Cardiovasc Surg. 1999 Feb;117(2):273–284. doi: 10.1016/S0022-5223(99)70423-X. [DOI] [PubMed] [Google Scholar]
  5. Czer L. S., Chaux A., Matloff J. M., DeRobertis M. A., Nessim S. A., Scarlata D., Khan S. S., Kass R. M., Tsai T. P., Blanche C. Ten-year experience with the St. Jude Medical valve for primary valve replacement. J Thorac Cardiovasc Surg. 1990 Jul;100(1):44–55. [PubMed] [Google Scholar]
  6. Davenport J., Hart R. G. Prosthetic valve endocarditis 1976-1987. Antibiotics, anticoagulation, and stroke. Stroke. 1990 Jul;21(7):993–999. doi: 10.1161/01.str.21.7.993. [DOI] [PubMed] [Google Scholar]
  7. Enriquez-Sarano M., Schaff H. V., Orszulak T. A., Tajik A. J., Bailey K. R., Frye R. L. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995 Feb 15;91(4):1022–1028. doi: 10.1161/01.cir.91.4.1022. [DOI] [PubMed] [Google Scholar]
  8. Eykyn S. J. Endocarditis: basics. Heart. 2001 Oct;86(4):476–480. doi: 10.1136/heart.86.4.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gallo I., Nistal F., Artiñano E. Six- to ten-year follow-up of patients with the Hancock cardiac bioprosthesis. Incidence of primary tissue valve failure. J Thorac Cardiovasc Surg. 1986 Jul;92(1):14–20. [PubMed] [Google Scholar]
  10. Gohlke-Bärwolf C. Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart. 2000 Nov;84(5):567–572. doi: 10.1136/heart.84.5.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Groves P. H., Lewis N. P., Ikram S., Maire R., Hall R. J. Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease. Br Heart J. 1991 Oct;66(4):295–301. doi: 10.1136/hrt.66.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Habicht J. M., Scherr P., Zerkowski H. R., Hoffmann A. Late conduction defects following aortic valve replacement. J Heart Valve Dis. 2000 Sep;9(5):629–632. [PubMed] [Google Scholar]
  13. Lindblom D., Lindblom U., Qvist J., Lundström H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990 Mar 1;15(3):566–573. doi: 10.1016/0735-1097(90)90627-2. [DOI] [PubMed] [Google Scholar]
  14. Lund O., Erlandsen M. Changes in left ventricular function and mass during serial investigations after valve replacement for aortic stenosis. J Heart Valve Dis. 2000 Jul;9(4):583–593. [PubMed] [Google Scholar]
  15. Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation. 1990 Jul;82(1):124–139. doi: 10.1161/01.cir.82.1.124. [DOI] [PubMed] [Google Scholar]
  16. Mahy I. R., Dougall H., Buckley A., Jeffrey R. R., Walton S., Jennings K. P. Routine hospital based follow up for patients with mechanical valve prostheses: is it worthwhile? Heart. 1999 Oct;82(4):520–522. doi: 10.1136/hrt.82.4.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nakano S., Sakai K., Taniguchi K., Miyamoto Y., Shintani H., Shimazaki Y., Matsuda H., Kawashima Y. Relation of impaired left ventricular function in mitral regurgitation to left ventricular contractile state after mitral valve replacement. Am J Cardiol. 1994 Jan 1;73(1):70–74. doi: 10.1016/0002-9149(94)90729-3. [DOI] [PubMed] [Google Scholar]
  18. Pagani F. D., Benedict M. B., Marshall B. L., Bolling S. F. The economics of uncomplicated mitral valve surgery. J Heart Valve Dis. 1997 Sep;6(5):466–469. [PubMed] [Google Scholar]
  19. Porter A., Shapira Y., Wurzel M., Sulkes J., Vaturi M., Adler Y., Sahar G., Sagie A. Tricuspid regurgitation late after mitral valve replacement: clinical and echocardiographic evaluation. J Heart Valve Dis. 1999 Jan;8(1):57–62. [PubMed] [Google Scholar]
  20. Ryder S. J., Bradley H., Brannan J. J., Turner M. A., Bain W. H. Thrombotic obstruction of the Björk-Shiley valve: the Glasgow experience. Thorax. 1984 Jul;39(7):487–492. doi: 10.1136/thx.39.7.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Villari B., Vassalli G., Monrad E. S., Chiariello M., Turina M., Hess O. M. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement. Circulation. 1995 May 1;91(9):2353–2358. doi: 10.1161/01.cir.91.9.2353. [DOI] [PubMed] [Google Scholar]
  22. Zieliński T., Pogorzelska H., Rajecka A., Biedermavn A., Sliwiński M., Korewicki J. Pulmonary hemodynamics at rest and effort, 6 and 12 months after mitral valve replacement: a slow regression of effort pulmonary hypertension. Int J Cardiol. 1993 Nov;42(1):57–62. doi: 10.1016/0167-5273(93)90102-m. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES